Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $12.12 USD
Change Today +0.20 / 1.68%
Volume 1.2M
MACK On Other Exchanges
Symbol
Exchange
NASDAQ GM
As of 8:10 PM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

Insiders at merrimack pharmaceuticals in (MACK)

Name (Connections)Board RelationshipsTitleType of Board MemberAge
Robert Mulroy 16 RelationshipsChief Executive Officer, President, Executive Director and Member of Executive CommitteeChief Executive Officer50
Michael Porter Ph.D.50 RelationshipsStrategy Advisor, Director, Chairman of Corporate Governance & Nominating Committee and Member of Executive CommitteeOther Professional67

Other Board Members on Board*

Name (Connections)Board RelationshipsType of Board MemberPrimary CompanyAge
Gary Crocker 62 RelationshipsChairman of the BoardCrocker Ventures62
Peter Sorger Ph.D. 39 RelationshipsMember of Advisory BoardMerrimack Pharmaceuticals, Inc.53
Gordon Fehr Ph.D. 16 RelationshipsMember of the Board of DirectorsMerrimack Pharmaceuticals, Inc.81
James Quigley 289 RelationshipsMember of the Board of DirectorsHess Corporation62
James Marks M.D., Ph.D. 53 RelationshipsMember of Advisory BoardHERMES Biosciences, Inc.--
Barret Rollins M.D., Ph.D. 29 RelationshipsMember of Advisory BoardDana-Farber Cancer Institute, Inc.--
Louis Weiner M.D. 52 RelationshipsMember of Advisory BoardLombardi Comprehensive Cancer Center62
Michael Yaffe M.D., Ph.D. 58 RelationshipsMember of Advisory BoardOn-Q-ity Inc.--
Ulrik Nielsen Ph.D. 25 RelationshipsMember of the Board of DirectorsSilver Creek Pharmaceuticals, Inc.42
Douglas Lauffenburger Ph.D. 65 RelationshipsMember of Advisory BoardMerrimack Pharmaceuticals, Inc.--
John Park M.D. 20 RelationshipsMember of Advisory BoardHERMES Biosciences, Inc.--
Christopher Benz M.D. 20 RelationshipsMember of Advisory BoardHERMES Biosciences, Inc.--
John Mendelsohn M.D. 166 RelationshipsMember of the Board of DirectorsProgenics Pharmaceuticals, Inc.77
Vivian Lee M.D., Ph.D., M.B.A. 33 RelationshipsMember of the Board of DirectorsUniversity of Utah Health Care.47
Russell Ray 50 RelationshipsMember of the Board of DirectorsHLM Venture Partners66
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MACK:US $12.12 USD +0.20

MACK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MACK.
View Industry Companies
 

Industry Analysis

MACK

Industry Average

Valuation MACK Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERRIMACK PHARMACEUTICALS IN, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.